Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo-Youl Kim

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Medical Sciences (Basel, Switzerland)|October 10, 2018
New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead CompoundsSoo-Youl Kim
Frontiers in Bioscience : a Journal and Virtual Library|May 25, 2006
Transglutaminase 2 in inflammationSoo-Youl Kim
BMB Reports|May 6, 2014
Special issues from High 1: KSBMB Winter WorkshopSoo-Youl Kim
Biomolecules & Therapeutics|March 14, 2015
Cancer metabolism: strategic diversion from targeting cancer drivers to targeting cancer suppliersSoo-Youl Kim
Biomolecules & Therapeutics|December 8, 2017
Cancer Metabolism: a Hope for Curing CancerSoo-Youl Kim
Biomolecules & Therapeutics|December 8, 2017
Cancer Energy Metabolism: Shutting Power off Cancer FactorySoo-Youl Kim
Archives of Pharmacal Research|January 11, 2015
Cancer metabolism: targeting cancer universalitySoo-Youl Kim
Archives of Pharmacal Research|January 19, 2019
Targeting cancer energy metabolism: a potential systemic cure for cancerSoo-Youl Kim
Biomolecules & Therapeutics|January 6, 2026
Targeting the Primordial Chaperone to Overcome Acquired Drug Resistance in Cancer: TG2-Mediated AutophagySoo-Youl Kim
BMB Reports|July 1, 2010
A new paradigm for cancer therapeutics developmentSoo-Youl Kim
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Medical Sciences (Basel, Switzerland)|October 10, 2018
New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead CompoundsSoo-Youl Kim
Frontiers in Bioscience : a Journal and Virtual Library|May 25, 2006
Transglutaminase 2 in inflammationSoo-Youl Kim
BMB Reports|May 6, 2014
Special issues from High 1: KSBMB Winter WorkshopSoo-Youl Kim
Biomolecules & Therapeutics|March 14, 2015
Cancer metabolism: strategic diversion from targeting cancer drivers to targeting cancer suppliersSoo-Youl Kim
Biomolecules & Therapeutics|December 8, 2017
Cancer Metabolism: a Hope for Curing CancerSoo-Youl Kim
Biomolecules & Therapeutics|December 8, 2017
Cancer Energy Metabolism: Shutting Power off Cancer FactorySoo-Youl Kim
Archives of Pharmacal Research|January 11, 2015
Cancer metabolism: targeting cancer universalitySoo-Youl Kim
Archives of Pharmacal Research|January 19, 2019
Targeting cancer energy metabolism: a potential systemic cure for cancerSoo-Youl Kim
Biomolecules & Therapeutics|January 6, 2026
Targeting the Primordial Chaperone to Overcome Acquired Drug Resistance in Cancer: TG2-Mediated AutophagySoo-Youl Kim
BMB Reports|July 1, 2010
A new paradigm for cancer therapeutics developmentSoo-Youl Kim
Pageof 15